Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05224115
What this trial is testing

Dosimetry of [11C]CHDI-180R and [11C]CHDI-626.

Who this might be right for
Huntington Disease
Universitaire Ziekenhuizen KU Leuven 6
Early research (Phase 1)Looking for participantsNCT06197139
What this trial is testing

A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Xinlu Wang 20
Very early researchNot Yet RecruitingNCT07420036
What this trial is testing

An Open-label, Single-arm, Single-center Study to Evaluate the Diagnostic Efficacy of a Novel PET Probe, 68Ga-SFB6-ZN01, in Patients With Malignant Tumors

Who this might be right for
Neoplasms
Zhongnan Hospital 98
Early research (Phase 1)Looking for participantsNCT07660055
What this trial is testing

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

Who this might be right for
Breast CancerNon-small Cell Lung Cancer (NSCLC)Gastric/Gastroesophageal Junction (GEJ) Cancer+1 more
Novartis Pharmaceuticals 156
Testing effectiveness (Phase 2)Active Not RecruitingNCT03631017
What this trial is testing

Imaging With a PET Agent for Detection of Cancers of the Head and Neck

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)WithdrawnNCT01048086
What this trial is testing

90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET)

Who this might be right for
NeuroblastomaNeuroendocrine Tumor
University of Iowa
Early research (Phase 1)Looking for participantsNCT06943495
What this trial is testing

Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Jean-Mathieu Beauregard 60
Early research (Phase 1)Study completedNCT02916537
What this trial is testing

Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057

Who this might be right for
Prostate Cancer
Cancer Targeted Technology 20
Early research (Phase 1)Looking for participantsNCT06894745
What this trial is testing

PET [89Zr]DFO-starPEG in Solid Tumors

Who this might be right for
Solid TumorSolid CarcinomaSoft Tissue Lesion
Robert Flavell, MD, PhD 13
Testing effectiveness (Phase 2)Looking for participantsNCT06970119
What this trial is testing

A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Yunhe Pharmaceutical (Tianjin) Co., Ltd 55
Early research (Phase 1)Ended earlyNCT06376253
What this trial is testing

A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers

Who this might be right for
Ovarian CancerLung Cancer
Novartis Pharmaceuticals 4
Very early researchLooking for participantsNCT07707531
What this trial is testing

Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer

Who this might be right for
Gastric CancerPancreatic Cancer
Huashan Hospital 10
Testing effectiveness (Phase 2)UnknownNCT06006104
What this trial is testing

Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 49
Not applicableWithdrawnNCT02558205
What this trial is testing

Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry

Who this might be right for
Hepatocellular Carcinoma
Rush University Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT07586046
What this trial is testing

Defining the Ablative Dose for Y-90 TARE

Who this might be right for
HCC - Hepatocellular Carcinoma
Northwestern University 30
Early research (Phase 1)Study completedNCT05723640
What this trial is testing

The Safety and Dosimetry Study of 177Lu-LNC1004 Injection

Who this might be right for
Solid Tumor, Unspecified, Adult
Yantai LNC Biotechnology Singapore PTE. LTD. 11
Early research (Phase 1)Study completedNCT00509301
What this trial is testing

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme
Peregrine Pharmaceuticals 12
Early research (Phase 1)Study completedNCT06398730
What this trial is testing

A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy Volunteers

Who this might be right for
Healthy Volunteers
GE Healthcare 22
Early research (Phase 1)Ended earlyNCT03188328
What this trial is testing

Safety, Tolerability, PK, Dosimetry, MTD and Preliminary Efficacy of Intra-lesionally Injected AvidinOX, Followed by IV Escalating Doses of [177Lu]DOTA-biotin in Pts With Injectable Solid Tumors or Lymphomas

Who this might be right for
Inoperable Solid Tumors or Lymphomas
Alfasigma S.p.A. 3
Not applicableStudy completedNCT04903340
What this trial is testing

Assessment of the Impact of Acquisition Time, Respiratory Gating and New Qclear Reconstruction Modalities on the Quantification of Dosimetry in Selective Internal Radiotherapy

Who this might be right for
Carcinoma, Hepatocellular
University Hospital, Bordeaux 30
Next Page